miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression

Conclusions: miR-1226-3p promotes sorafenib sensitivity of HCC through downregulation of DUSP4 expression, and targeting miR-1226-3p may be a novel therapeutic strategy for overcoming sorafenib resistance.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Xianqing Chen, Wenliang Tan, Wenxin Li, Wenda Li, Sicong Zhu, Jinyi Zhong, Changzhen Shang, Yajin Chen Tags: Research Paper Source Type: research